Last reviewed · How we verify
Clopidogrel 600 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Clopidogrel 600 mg (Clopidogrel 600 mg) — Dong-A University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clopidogrel 600 mg TARGET | Clopidogrel 600 mg | Dong-A University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clopidogrel 600 mg CI watch — RSS
- Clopidogrel 600 mg CI watch — Atom
- Clopidogrel 600 mg CI watch — JSON
- Clopidogrel 600 mg alone — RSS
Cite this brief
Drug Landscape (2026). Clopidogrel 600 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/clopidogrel-600-mg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing